Overview

Improving Medication Compliance and Smoking Cessation Treatment Outcomes for African American Smokers

Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Little is known about the support needed to improve compliance with Chantix for smoking cessation. This is a two arm pilot study of African American smokers to provide varying levels of side effect management and compliance support during a 12 week treatment period. The primary aim of the study is to estimate the effect of induction support compared to standard care in increasing compliance with Chantix at month 3
Phase:
N/A
Details
Lead Sponsor:
Nikki Nollen, PhD, MA
Treatments:
Varenicline